Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease A Scientific Statement From the American Heart Association.

The article discusses on the thrombosis' prevention and treatment in pediatric and congenital heart disease. It explores the hemostasis in children with information on initiation of coagulation, amplification, and regulation of thrombin and fibrin. It highlights the agents for its treatment and prevention, such as heparin-induced thrombocytepenia and measures of anticoagulant effect. It also focuses on the special considerations with warfarin therapy in children.